MetaVia Inc. is trading 5% down at $1.79 as traders react to last week’s shareholder approval of a reverse stock split and an expanded equity incentive plan.
- The approval has raised significant concerns regarding future share dilution and balance-sheet optics, leading to several sessions of sharp declines.
- Today's weakness is compounded by a broadly lower market and renewed selling pressure on high-beta, speculative growth names.